MedPath

The Optimal Temperature for Replacement Fluid and Dialysate in Continuous Renal Replacement therapy (CRRT): A randomized controlled study

Phase 3
Recruiting
Conditions
Acute kidney injury requiring continuous renal replacement therapy in ICU
Continuous renal replacement therapy
Acute kidney injury
Dialysate temperature
Replacement fluid temperature
Registration Number
TCTR20171117001
Lead Sponsor
Renal Division, Department of Internal Medicine, Chiang Mai University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

1. Patient age of more than 15 years
2. Patients who require continuous renal replacement therapy
3. Patients or relatives gave written informed consent

Exclusion Criteria

1. Kidney transplant patients
2. Patients whom treated with slow continuous ultrafiltration (SCUF)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Stable hemodynamics 4 hours Blood pressure and norepinephrine dose
Secondary Outcome Measures
NameTimeMethod
Stable hemodynamics 8 hours Blood pressure and norepinephrine dose,Blood lactate 8 hours Accusport, Roche Diagnostics,Death rate In hospital Percentage of patients who died
© Copyright 2025. All Rights Reserved by MedPath